You are here

Zarxio

Amgen, Novartis Court Case May Ease US Launch of Biosimilars

Bidness, ETC

Thu, 06/23/16 - 09:56 am

Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in

Fierce Pharma

Thu, 03/31/16 - 09:39 pm

Amgen Asks the Supreme Court to Reject Challenge to Ruling that Notice of Commercial Marketing is Mandatory, But Asks for Review of Patent Dance Ruling Just in Case

FDA Law Blog

Tue, 03/29/16 - 11:12 am

Sandoz asks Supreme Court to nix 'exclusivity windfall' delaying biosimilar launches

Fierce Pharma

Sat, 02/20/16 - 09:22 am

Sandoz Petitions High Court to Review the Federal Circuit’s Decision on the BPCIA’s 180-Day Notice of Commercial Marketing Provision

FDA Law Blog

Wed, 02/17/16 - 11:33 am

Can Pharma Learn to Stop Worrying and Love Biosimilars?

Forbes

Thu, 02/11/16 - 08:28 am

An update on first-ever US biosim Zarxio 2 weeks after its debut

BioPharma Dive

Fri, 09/18/15 - 11:42 am

First 'biosimilar' drug launches in the US, years after other countries

Yahoo/AP

Thu, 09/10/15 - 06:04 pm

Sandoz: Zarxio marketing to be similar to a branded-drug launch

Fierce Pharma Marketing

Thu, 09/3/15 - 06:46 pm

Novartis launches first U.S. 'biosimilar' drug at 15 pct discount

Yahoo/Reuters

Thu, 09/3/15 - 08:45 am

Amgen cannot stop imminent sale of Neupogen copycat: US appeals court

Yahoo/Reuters

Wed, 09/2/15 - 12:37 pm

Amgen: Waiting for Clarity on Generic Biotech

Barron's

Fri, 08/21/15 - 11:05 am

Novartis blocked from selling Neupogen copycat until Sept. 2

Yahoo/Reuters

Tue, 07/21/15 - 12:47 pm

This Key Amgen Drug Is Setting a Precedent

Investopedia

Tue, 06/9/15 - 09:55 am

Novartis tries to get U.S. ban lifted on sale of Neupogen copycat

Yahoo/Reuters

Wed, 06/3/15 - 07:37 pm

Amgen motion to delay Neupogen biosimilar denied

Medical Marketing and Media

Fri, 04/17/15 - 08:44 am

Amgen loses another round in its battle to fend off a biosimilar rival

Marketwatch

Mon, 03/30/15 - 09:23 pm

Denied Again! Another Obstacle to Biosimilar First Launch Falls with FDA Rejection of Amgen’s Certification Petition

FDA Law Blog

Fri, 03/27/15 - 08:39 am

Amgen to appeal rejection of bid to block Novartis biosimilar drug

Yahoo/Reuters

Wed, 03/25/15 - 03:18 pm

Amgen: The biotech that's getting on the biosimilar R&D bandwagon

BioPharma Dive

Wed, 03/11/15 - 08:38 am

Pages